| Dr Gerard Fitzgerald Sigue, MD | |
|
217 Gleneagles Cir, Broussard, LA 70518-6185 | |
| (337) 608-9043 | |
| Not Available |
| Full Name | Dr Gerard Fitzgerald Sigue |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 30 Years |
| Location | 217 Gleneagles Cir, Broussard, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750390316 | NPI | - | NPPES |
| 1676543 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 022140 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dci - Bayou Teche | New iberia, LA | Dialysis facility |
| Fmcna - New Iberia | New iberia, LA | Dialysis facility |
| Fmcna - Franklin | Franklin, LA | Dialysis facility |
| Apex Home Health-south, Llc | La place, LA | Home health agency |
| Iberia Medical Center | New iberia, LA | Hospital |
| Franklin Foundation Hospital | Franklin, LA | Hospital |
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iberia Medical Center Physician Practice Network | 3476730847 | 18 |
News Archive
Burn patients need support to transition to burn survivors. That's why Thereasa Abrams, an assistant professor in the University of Tennessee, Knoxville's College of Social Work and a burn survivor herself, has developed an app called the Bridge to help them heal faster.
Intertek, the global testing, auditing and certification organisation, have launched a series of training sessions in South Africa to promote food safety within the country.
The Barnett Shale Energy Education Council today released the results of its air quality testing project which showed there are no harmful levels of benzene and other compounds being emitted from natural gas sites tested in Fort Worth and Arlington City Council District 2.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), today announced that it presented the results of a preclinical study on a prototype HIV/AIDS vaccine at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.
› Verified 1 days ago
| Entity Name | Iberia Medical Center Physician Practice Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518265297 PECOS PAC ID: 3476730847 Enrollment ID: O20110613000164 |
News Archive
Burn patients need support to transition to burn survivors. That's why Thereasa Abrams, an assistant professor in the University of Tennessee, Knoxville's College of Social Work and a burn survivor herself, has developed an app called the Bridge to help them heal faster.
Intertek, the global testing, auditing and certification organisation, have launched a series of training sessions in South Africa to promote food safety within the country.
The Barnett Shale Energy Education Council today released the results of its air quality testing project which showed there are no harmful levels of benzene and other compounds being emitted from natural gas sites tested in Fort Worth and Arlington City Council District 2.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), today announced that it presented the results of a preclinical study on a prototype HIV/AIDS vaccine at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.
› Verified 1 days ago
| Entity Name | Gerard F. Sigue Md Ms, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194095109 PECOS PAC ID: 0244495471 Enrollment ID: O20120712000875 |
News Archive
Burn patients need support to transition to burn survivors. That's why Thereasa Abrams, an assistant professor in the University of Tennessee, Knoxville's College of Social Work and a burn survivor herself, has developed an app called the Bridge to help them heal faster.
Intertek, the global testing, auditing and certification organisation, have launched a series of training sessions in South Africa to promote food safety within the country.
The Barnett Shale Energy Education Council today released the results of its air quality testing project which showed there are no harmful levels of benzene and other compounds being emitted from natural gas sites tested in Fort Worth and Arlington City Council District 2.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), today announced that it presented the results of a preclinical study on a prototype HIV/AIDS vaccine at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerard Fitzgerald Sigue, MD 2308 E Main St, Suite E, New Iberia, LA 70560-4041 Ph: (337) 608-9043 | Dr Gerard Fitzgerald Sigue, MD 217 Gleneagles Cir, Broussard, LA 70518-6185 Ph: (337) 608-9043 |
News Archive
Burn patients need support to transition to burn survivors. That's why Thereasa Abrams, an assistant professor in the University of Tennessee, Knoxville's College of Social Work and a burn survivor herself, has developed an app called the Bridge to help them heal faster.
Intertek, the global testing, auditing and certification organisation, have launched a series of training sessions in South Africa to promote food safety within the country.
The Barnett Shale Energy Education Council today released the results of its air quality testing project which showed there are no harmful levels of benzene and other compounds being emitted from natural gas sites tested in Fort Worth and Arlington City Council District 2.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), today announced that it presented the results of a preclinical study on a prototype HIV/AIDS vaccine at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
When San Francisco voters overwhelmingly approved a ballot measure banning the sale of flavored tobacco products in 2018, public health advocates celebrated. After all, tobacco use poses a significant threat to public health and health equity, and flavors are particularly attractive to youth.
› Verified 1 days ago
Dr. Madelaine Fahrmann Fontenot, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1122 S Bernard Rd, Suite B, Broussard, LA 70518 Phone: 337-289-8933 | |
Dr. Jeffrey Douglas Fontenot, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1122 South Bernard Rd, Suite B, Broussard, LA 70518 Phone: 337-289-8933 | |
Jorge Rafael Belgodere-bonilla, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 811 Albertson Pkwy Ste F, Broussard, LA 70518 Phone: 337-837-3615 Fax: 337-839-8097 |